Article
A signature of 33 immune‐related gene pairs predicts clinical outcome in hepatocellular carcinoma
18 Feb 2020
Abstract excerpt
OBJECTIVE: Hepatocellular carcinoma (HCC) has become the second most common tumor type that contributes to cancer-related death worldwide. The study aimed to establish a robust immune-related gene pair (IRGP) signature for predicting the prognosis of HCC patients. METHODS: Two RNA-seq datasets (The Cancer Genome Atlas Program and International Cancer Genome Consortium) and one microarray dataset (GSE14520) were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
